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Background/aim: To determine the relationship between human leukocyte antigen (HLA) antigens and osteoarticular brucellosis by
evaluating HLA Class I and II antigens in control subjects and patients developing osteoarticular brucellosis in Turkey.
Materials and methods: The study included 28 patients with osteoarticular involvement diagnosed with brucellosis and 100 controls.
The HLA Class I and II antigens were studied in isolated DNA samples using sequence-specific oligonucleotide procedure.
Results: The mean age of the 28 patients and 100 controls was 42.3 ± 20.2 years and 50.1 ± 16.3 years, respectively. When the frequency
of HLA Class I was examined, HLA-A*02 and HLA-B*27 antigens were detected in 50% and 28.57% of the patients, respectively.
However, there was no significant difference when compared to the control group. Among the HLA Class I antigens, HLA-Cw*10 was
determined in 35.71% of the patients and 17% of the controls; the difference was significant (P = 0.039).
Conclusion: In the development of brucellosis, the frequency of HLA-Cw*10 among HLA Class I antigens was observed to be increased,
and HLA-Cw*10 was considered likely to cause predisposition to brucellosis. Further studies to be performed on a higher number of
patients and controls could demonstrate that genetic factors play a role in the diagnosis of osteoarticular brucellosis.
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1. Introduction
Brucellosis is a polymorphic disease that may involve any
organ in the body. Osteoarticular involvement is the most
common type. Osteoarticular brucellosis can present as
peripheral arthritis, sacroiliitis, spondylitis, tenosynovitis,
bursitis, and osteomyelitis. Large- and medium-sized
peripheral joints, sacroiliac joints, and the spinal region are
the most commonly involved sites (1–3). Recent studies
have supported the hypothesis that genetic predisposition
associated with human leukocyte antigen (HLA) genes plays
a role in the development of osteoarticular complications.
In the studies conducted, mostly HLA-A*02, HLA-B*27,
and HLA-B*39, which are HLA Class I antigens, have
been detected (4,5). The relationship of these tissue group
antigens with osteoarticular involvement of brucellosis
is not exactly known. Although there are several studies
on the relationship of HLA-A*02 and HLA-B*27 antigens
with arthritis and arthralgia, studies on the tissue group
antigens that are common in osteoarticular brucellosis in
Turkey are limited. The present study aims to determine
the relationship of HLA antigens with osteoarticular
brucellosis by evaluating HLA antigens in patients
* Correspondence: sevgonen@gmail.com

developing osteoarticular brucellosis and control subjects
in Turkey. Moreover, whereas the literature contains data
on only HLA Class I antigens, we also studied HLA Class
II antigens.
2. Materials and methods
The present study included 28 patients admitted to the
Department of Infectious Diseases of the Faculty of Medicine,
Gazi University, in 2014 and 2015, and diagnosed with
osteoarticular involvement of brucellosis. For the control
group, we selected 100 healthy renal transplant donors
without any disease that had been admitted to the Tissue
Typing Laboratory of our hospital. DNA samples of the
patients and controls were isolated from the blood samples
containing ethylenediaminetetraacetic acid (EDTA), using
the BioRobot EZ1 system (QIAGEN, Hilden, Germany).
HLA Class I and II antigens were studied in these isolated
DNA samples using the polymerase chain reaction (PCR)
sequence-specific oligonucleotide (PCR-SSO-Luminex;
Gene-Probe Lifecodes, Stanford, CA, USA) procedure.
The samples were studied according to the method
described by the manufacturer (6). Briefly, 10 μL of DNA
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sample from each patient was pipetted into the PCR tubes.
We added 15 μL of ready-to-use MasterMix provided by
the manufacturer to each PCR tube, and the DNA samples
were amplified in a thermal cycler using the recommended
program. Next 5 μL of PCR product was aliquoted into a
Costar plate to provide the hybridization of the amplified
DNA samples with specific oligonucleotides on a solid
medium (wells or beads). We then added 15 μL of bead
mix and covered the plate with a seal. Hybridization was
initiated in the thermal cycler by selecting the program
recommended by the manufacturer. Various reagents (a
mixture of phycoerythrin and streptavidin) were used to
visualize the hybridized oligonucleotide probes and HLA
alleles. At the end of the test run, the results were analyzed
using Quick-Type in the Luminex-Life-Match device. The
present study was approved by the Ethics Committee of
Gazi University, and informed consent of the patients was
obtained.
2.1. Statistical analysis
Data analysis was performed using chi-square test and
Fisher’s exact test. Statistical significance was assessed
using Fisher’s exact test. P < 0.05 was considered

statistically significant. Data are presented as mean ±
standard deviation. The Shapiro–Wilk test was used to
assess the normality of variable distribution. Since the
group sizes were vastly unequal, homogeneity of variance
was checked with Levene’s test. No differences in variance
were found between the patient and control groups, and
distribution was normal.
3. Results
The mean age of 28 patients (16 male and 12 female), who
had osteoarticular involvement and were diagnosed with
brucellosis, was 42.3 ± 20.2 years, and the mean age of 100
healthy donor candidates (49 male and 51 female) was 50.1
± 16.3 years. In accordance with the study method, all HLA
Class I and II antigens were evaluated both in the patient
group, with osteoarticular brucellosis, and in the control
group. The frequencies of HLA Class I and II antigens in
the patient and control groups are presented in Tables 1
and 2, respectively. When the frequency of HLA Class I
antigens was examined, HLA-A*02 and HLA-B*27 were
detected in 50% and 28.57% of the patients, respectively.
However, there was no significant difference compared to

Table 1. Frequency of HLA Class I antigens in the patient and control groups.

HLA Class I antigens

Patient group
n = 28

Control group
n = 100

P

n (%)

n (%)

HLA-A*02

14 (50)

39 (39)

0.408

HLA-A*24

7 (25)

25 (25)

1.000

HLA-B*27

8 (28.57)

16 (16)

0.218

HLA-B*35

8 (28.57)

32 (32)

0.908

HLA-Cw*10

10 (35.71)

17 (17)

0.039

HLA-Cw*12

8 (28.57)

33 (33)

0.830

HLA: human leukocyte antigen.
Table 2. Frequency of HLA Class II antigens in the patient and control groups.

HLA Class II antigens

Control group
n = 100

P

n (%)

n (%)

HLA-DRB1*11

11 (39.28)

43 (43)

0.892

HLA-DRB1*04

10 (35.71)

23 (23)

0.265

HLA-DRB1*15

8 (28.57)

20 (20)

0.477

HLA-DQB1*03

21 (75)

70 (70)

0.779

HLA-DQB1*05

10 (35.71)

43 (43)

0.635

HLA-DQB1*06

9 (32.14)

20 (20)

0.271

HLA: human leukocyte antigen.
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the control group. Among the HLA Class I antigens, HLACw*10 was determined in 35.71% of the patients and 17%
of the controls. The difference was found to be significant
(P = 0.039). The frequency of HLA Class II antigens was
similar in the patient and control groups.
4. Discussion
In brucellosis, which is primarily a reticuloendothelial
system disease, osteoarticular involvement (spondylitis,
peripheral arthritis, sacroiliitis, and osteomyelitis) is the
most common (7,8). In the literature, there are several
studies evaluating the relationship between osteoarticular
involvement of brucellosis and various tissue groups. In
the present study, the most common HLA Class I antigens
were HLA-A*02, HLA-A*24, HLA-B*27, HLA-B*35,
HLA-Cw*10, and HLA-Cw*12. The most common HLA
Class II antigens were HLA-DRB1*04, HLA-DRB1*11,
HLA-DRB1*15, HLA-DQB1*03, HLA-DQB1*05, and
HLA-DQB1*06. Particularly, HLA-Cw*10 significantly
more frequent in the patients with osteoarticular
involvement. No significant difference was found between
the patient and control groups in terms of the other tissue
group antigens.
In the present study, although the frequencies of
HLA-A*02 and HLA-B*27 antigens were 50% and 28.57%,
respectively, no significant difference was determined in
the patient group compared to the controls. The frequency
of HLA-Cw*10 antigen was 35.71% in the patient group,
which was significantly higher than in the control group
(17%; P < 0.039). Studies on HLA-Cw* antigens are
limited. In a single study on ankylosing spondylitis, HLACw*10 antigen was found to be significant (9). To the best
of our knowledge, there is no study in the literature on
the relation of HLA-Cw*10 antigen with brucellosis. The
present study is the first to demonstrate this relationship.
However, our study has a small sample size, and further
studies with larger sample sizes are required in the long

term. Although there are studies demonstrating the
relation between HLA-B*27 antigen and osteoarticular
brucellosis in the literature, we did not find a significant
difference between the patient and control groups in terms
of the frequency of HLA-B*27 antigen. There are limited
studies on the HLA Class II antigens, and their relation
with osteoarticular brucellosis has not been reported yet.
Consistently with reports in the literature, no relation was
found between HLA Class II antigens and osteoarticular
brucellosis in the present study.
There are many studies investigating the genetic factors
that play a role in susceptibility to infectious diseases, and
several of these studies focus on HLA. The relation of host
HLA with bacterial, viral, fungal, and parasitic infections
has been widely investigated (10,11). The type and strength
of this relationship vary depending on the racial/ethnic
characteristics of the population. Certain types of HLA
antigens are more frequent in some diseases. Studies on
patients with rheumatic diseases can be given as examples
(12,13). Osteoarticular involvement is a frequent and
treatable complication of brucellosis. It has been thought
that the pathogenesis of osteoarticular involvement might
be infectious or reactive, and it has been suggested that
osteoarticular complications might be more prevalent in
patients carrying HLA-B*27 antigen in endemic regions
(14). In other studies investigating the relationship between
osteoarticular involvement and genetic predisposition, the
frequency and severity of osteoarticular complications
were determined to be significantly higher in individuals
carrying HLA-A*02 and HLA-B*39 antigens (15,16).
In conclusion, high frequency of HLA-Cw*10 antigen
was determined to be associated with the development of
osteoarticular brucellosis. Studies performed on a higher
number of patients and controls can confirm that genetic
factors (HLA antigens) may play a role in diagnosing
osteoarticular brucellosis.
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